Synapse - Works

Results (601)

Weekly carfilzomib, lenalidomide, dexamethasone and daratumumab (wKRd-D) combination therapy provides unprecedented MRD negativity rates in newly diagnosed multiple myeloma: A clinical and correlative phase 2 study

Meeting Abstract

Landgren, O.; Hultcrantz, M.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; Smith, E. L.; Shah, U. A.; Lu, S. X.; Mastey, D.; Salcedo, M.; more...
Blood (2019)

Fulltext@MSK | Save

Extended mutational profiling by MSK-IMPACT™ identifies mutations predicting thromboembolic risk in patients with solid tumor malignancy

Meeting Abstract

Dunbar, A.; Bolton, K.; Devlin, S. M.; Sanchez-Vega, F.; Gao, J.; Mones, J. V.; Wills, J. M.; Kelly, D.; Farina, M.; Kishore, S.; more...
Blood (2019)

Fulltext@MSK | Save

TP53 state dictates genome stability, clinical presentation and outcomes in myelodysplastic syndromes

Meeting Abstract

Bernard, E.; Nannya, Y.; Yoshizato, T.; Hasserjian, R. P.; Saiki, R.; Shiozawa, Y.; Devlin, S. M.; Tuechler, H.; Sarian, A.; Malcovati, L.; more...
Blood (2019)

Fulltext@MSK | Save

RAS mutations are independently associated with decreased overall survival and event-free survival in patients with AML receiving induction chemotherapy

Meeting Abstract

Ball, B. J.; Hsu, M.; Devlin, S. M.; Famulare, C.; Cai, S. F.; Dunbar, A.; Epstein-Peterson, Z. D.; Menghrajani, K.; Glass, J. L.; Taylor, J.; more...
Blood (2019)

Fulltext@MSK | Save

RAS mutations are independently associated with decreased overall survival and event-free survival in patients with AML receiving induction chemotherapy

Meeting Abstract

Ball, B. J.; Hsu, M.; Devlin, S. M.; Famulare, C.; Cai, S. F.; Dunbar, A.; Epstein-Peterson, Z. D.; Menghrajani, K.; Glass, J. L.; Taylor, J.; more...
Blood (2019)

Fulltext@MSK | Save

Feasibility of a patient-reported, electronic geriatric assessment tool in hematopoietic cell transplantation - A single institution pilot study

Research Letter

Lin, R. J.; Dahi, P. B.; Shahrokni, A.; Sarraf, S.; Korc-Grodzicki, B.; Devlin, S. M.; Maloy, M. A.; Shah, G. L.; Jakubowski, A. A.; Giralt, S. A.
Leukemia and Lymphoma (2019)

Fulltext@MSK | Save

T cell-derived interferon-γ programs stem cell death in immune-mediated intestinal damage

Journal Article

Takashima, S.; Martin, M. L.; Jansen, S. A.; Fu, Y.; Bos, J.; Chandra, D.; O'Connor, M. H.; Mertelsmann, A. M.; Vinci, P.; Kuttiyara, J.; more...
Science Immunology (2019)

Fulltext@MSK | Save

Lactose drives Enterococcus expansion to promote graft-versus-host disease

Journal Article

Stein-Thoeringer, C. K.; Nichols, K. B.; Lazrak, A.; Docampo, M. D.; Slingerland, A. E.; Slingerland, J. B.; Clurman, A. G.; Armijo, G.; Gomes, A. L. C.; Shono, Y.; more...
Science (2019)

Fulltext@MSK | Save

Successful pharmacokinetic (PK)-directed dosing of Evomela® (propylene glycol free melphalan, PGF-MEL) for Multiple Myeloma (MM) and AL Amyloidosis (AL) patients undergoing autologous hematopoietic stem cell transplant (AHCT)

Meeting Abstract

Shah, G.; Lin, A.; Grumley, A.; Kamrowski, A.; Schofield, R.; Devlin, S.; Bhatt, V.; Proli, A.; Chung, D.; Dahi, P.; more...
Clinical Lymphoma, Myeloma and Leukemia (2019)

Fulltext@MSK | Save

Interleukin-6 (IL-6) blockade with siltuximab peri-autologous hematopoietic stem cell transplantation (AHCT) may reduce symptom burden by altering the cytokine milieu in older patients with multiple myeloma (MM)

Meeting Abstract

Shah, G.; Holder, J.; Cho, S.; Murata, K.; Devlin, S.; Hoover, E.; Chung, D.; Dahi, P.; Lahoud, O.; Scordo, M.; more...
Clinical Lymphoma, Myeloma and Leukemia (2019)

Fulltext@MSK | Save